Selbyville, Delaware, April 28, 2021 (GLOBE NEWSWIRE) -- As per reliable analysts, global infectious diseases in-vitro diagnostics market size was appraised at USD 54 billion in the year 2019 and is expected to register a y-o-y growth rate of 3.8% during 2020-2027, subsequently accounting for USD 73 billion by the year 2027. Shifting preferences towards adopting point-of-care diagnostic tools, high occurrence of infectious diseases, and favorable government regulations have resulted in increased product penetration across the globe.
A detailed analysis of the different market segmentations is also included in the report, alongside their respective contribution towards the overall market outlook. Additionally, the study offers descriptive information regarding the regional scope and the competitive arena of this industry vertical, allowing for high quality decision making as well as profitability while investing in new ventures.
For the unversed, infectious in-vitro diagnostics is a medical device that involves the use of assays and reagents to treat particular medical conditions. The information acquired through these diagnostic tools allows physicians to effectively manage the required medical settings at each stage.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3611211/
There have also been significant advancements in in-vitro diagnostics which has resulted in paradigm shift to laboratory testing from point-of-care systems, thereby stimulating the overall industry outlook. However, high costs associated with the product could potentially act as a restraining factor to global infectious diseases in-vitro diagnostics industry expansion.
Summarizing the market segmentations
Global infectious diseases in-vitro diagnostics industry is segmented into product varieties, technology type, application scope, and end-user spectrum.
The product spectrum consists of services, reagent, and instruments segment. Moving on to technology type, the market is split into microbiology, molecular diagnostics, immunoassay, and others.
Based on application spectrum, global infectious diseases in-vitro diagnostics industry is bifurcated into chlamydia, gonorrhea, HIV, tuberculosis and drug-resistant TB, respiratory virus, carbapenem-resistant enterobacterial testing, clostridium difficile, streptococcus, and others.
The end-user spectrum of the overall market consists of central laboratories, point of care, and others.
Highlighting the geographical reach
Worldwide infectious diseases in-vitro diagnostics industry is fragmented on the basis of North America, Latin America, Asia-Pacific, and Europe.
According to credible estimations, North America currently dominates the market space in terms of revenue share and is likely to show consistent growth in the ensuing years. Factors such as widespread adoption of point-of-care diagnostic devices coupled with high concentration of major companies are facilitating the business scenario in North America.
Asia-Pacific, meanwhile, is also expected to generate lucrative returns for the industry participants in the forthcoming years. This robust growth can be attributed to increased pervasiveness of infectious diseases and improving healthcare infrastructure.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
Global Infectious Diseases in-Vitro Diagnostics Market Product Spectrum (Revenue, USD Billion, 2017-2027)
- Services
- Reagent
- Instruments
Global Infectious Diseases in-Vitro Diagnostics Market by Technology Type (Revenue, USD Billion, 2017-2027)
- Microbiology
- Molecular Diagnostics
- Immunoassay
- Others
Global Infectious Diseases in-Vitro Diagnostics Market Application Terrain (Revenue, USD Billion, 2017-2027)
- Chlamydia
- Gonorrhea
- Human Immunodeficiency Virus (HIV)
- Tuberculosis & drug-resistant TB
- Respiratory Virus
- Carbapenem-resistant enterobacterial testing (CRE)
- Clostridium Difficile
- Streptococcus
- Others
Global Infectious Diseases in-Vitro Diagnostics Market End-user Analysis (Revenue, USD Billion, 2017-2027)
- Central Laboratories
- Point of Care
- Others
Global Infectious Diseases in-Vitro Diagnostics Market by Geographical Reach (Revenue, USD Billion, 2017-2027)
North America
- United States
- Canada
Europe
- Italy
- Spain
- France
- United Kingdom
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Asia-Pacific
- South Korea
- Japan
- Australia
- China
- India
- Rest of Asia-Pacific
Rest of the World
Global Infectious Diseases in-Vitro Diagnostics Market Competitive Dynamics (Revenue, USD Billion, 2017-2027)
- Bio-Rad Laboratories Inc.
- Siemens Healthineers AG
- F. Hoffmann-La Roche AG
- QIAGEN
- Hologic Inc.
- OraSure Technologies
- Quidel Corporation
- Abbott Laboratories
- bioMérieux SA
- Becton, Dickinson and Company
Table of Content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Region, 2018-2027 (USD Billion)
1.2.2. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Product, 2018-2027 (USD Billion)
1.2.3. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Technology, 2018-2027 (USD Billion)
1.2.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Application, 2018-2027 (USD Billion)
1.2.5. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by End-Use, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Dynamics
3.1. Infectious Diseases in-Vitro Diagnostics (IVD) Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Product
5.1. Market Snapshot
5.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Product, Performance - Potential Analysis
5.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
5.4.1. Instruments
5.4.2. Reagent
5.4.3. Services
Chapter 6. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Technology
6.1. Market Snapshot
6.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Technology, Performance - Potential Analysis
6.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
6.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
6.4.1. Immunoassay
6.4.2. Molecular Diagnostics
6.4.3. Microbiology
6.4.4. Others
Chapter 7. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Application
7.1. Market Snapshot
7.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Application, Performance - Potential Analysis
7.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
7.4.1. Streptococcus
7.4.2. Clostridium Difficile
7.4.3. Carbapenem-resistant enterobacterial testing (CRE)
7.4.4. Respiratory virus
7.4.5. Tuberculosis (TB) & drug-resistant TB
7.4.6. Human Immunodeficiency Virus (HIV)
7.4.7. Gonorrhea
7.4.8. Chlamydia
7.4.9. Others
Chapter 8. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by End-Use
8.1. Market Snapshot
8.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by End-Use - Potential Analysis
8.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)
8.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
8.4.1. Point of Care
8.4.2. Central Laboratories
8.4.3. Others
Chapter 9. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, Regional Analysis
Related Report:
In-vitro Diagnostics Market Size, Application Potential, Competitive Market Share & Forecast, 2019 - 2025
In-vitro Diagnostics Market will exceed USD 97.2 billion by 2025; as per a new research report. Increasing number of pathology labs equipped with advanced diagnostics machine will prove beneficial for in-vitro diagnostics market growth in near future. Now a days, pathology labs are incorporating latest technology instruments to provide superior quality services to patients. Moreover, advanced technology enables in detection of several diseases before their onset. This in turn enhances overall clinical outcome that will prevent further complications. As a result, growing number of laboratories incorporating technologically advanced machines will augment in-vitro diagnostics market growth over the forecast period.
Rising preference towards personalized medicines for treatment of several chronic diseases will accelerate demand for in-vitro diagnostics in forthcoming future. Advantages of personalized medicines such as optimum dosage delivery, target and accurate treatment will rise preference towards it. Thus, demand for IVD will substantially grow to develop new therapies for treating chronic disorders. However, high cost of in-vitro diagnostic services may hinder market growth to certain extent.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.